|
(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Primary biliary cirrhosis |
| USA Market Approval | USA |
| USA Designation Date | 2012-10-31 00:00:00 |
| Sponsor | Albireo AB;Arvid Wallgrens Backe 20, S-413 46 Gothenburg; |
